NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

9475	Companies
185442	Keywords
117783	Articles
99298	Press releases

Home
Companies
NanoViricides, Inc.

PRESS RELEASE

published on 08/18/2025 at 14:30, 3 months 17 days ago

A Drug that Could Reduce Metastatic Cancer Resurgence due to Its Anti-Inflammatory Effects in Viral Infections is in Clinical Trials
NanoViricides, Inc. reports NV-387 antiviral drug could reduce metastatic cancer resurgence caused by viral infections. NV-387 completed Phase I trial, advancing to Phase II

NV-387 NanoViricides Inc. Antiviral Drug Viral Infections Metastatic Cancer
BRIEF

published on 07/30/2025 at 14:35, 4 months 5 days ago

NanoViricides présente le NV-387 comme une solution clé contre la rougeole face à l'augmentation des cas

Désignation De Médicament Orphelin Médicament NV-387 Augmentation De La Rougeole Vaccination Mondiale Risque Pour La Santé Publique
BRIEF

published on 07/30/2025 at 14:35, 4 months 5 days ago

NanoViricides Highlights NV-387 as Key Measles Solution Amid Rising Cases

Orphan Drug Designation NV-387 Drug Measles Increase Global Vaccination Public Health Risk
PRESS RELEASE

published on 07/30/2025 at 14:30, 4 months 5 days ago

Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides
NanoViricides introduces drug candidate NV-387 as a potential treatment for Measles outbreak. The drug has shown safety and effectiveness in animal studies and Phase I trial, aiming to combat the global epidemic

NanoViricides NV-387 Antiviral Vaccination Measles
BRIEF

published on 07/23/2025 at 14:35, 4 months 12 days ago

NanoViricides Explores Potential of Broad-Spectrum Antiviral NV-387

NV-387 Regulatory Approval Broad-spectrum Antiviral Pandemic Preparedness Orphan Drug Status
BRIEF

published on 07/23/2025 at 14:35, 4 months 12 days ago

NanoViricides explore le potentiel de l'antiviral à large spectre NV-387

NV-387 Antiviral À Large Spectre Approbation Réglementaire Préparation Aux Pandémies Statut De Médicament Orphelin
PRESS RELEASE

published on 07/23/2025 at 14:30, 4 months 12 days ago

NanoViricides Discusses the Multi-Billion-Dollar Potential of Its Broad-Spectrum Drug NV-387; Its Effectiveness Against Influenza, Coronaviruses, RSV, MPox and Now Measles Expected to Drive Value
NanoViricides, Inc. highlights the strong effectiveness of its broad-spectrum antiviral drug NV-387 against various viruses. Expected to drive significant valuation and market share, leading to rapid regulatory approvals and early revenues

NanoViricides NV-387 Antiviral Drug Broad-spectrum Pandemic Preparedness
BRIEF

published on 07/21/2025 at 12:35, 4 months 14 days ago

NanoViricides Develops Promising Measles Antiviral

NanoViricides NV-387 Antiviral Drug Animal Study Measles Treatment
BRIEF

published on 07/21/2025 at 12:35, 4 months 14 days ago

NanoViricides développe un antiviral prometteur contre la rougeole

NanoViricides NV-387 Médicament Antiviral Étude Animale Traitement De La Rougeole
PRESS RELEASE

published on 07/21/2025 at 12:30, 4 months 14 days ago

Measles Now Has a Drug - NV-387 Broad-Spectrum Antiviral Successful in Animal Studies, says NanoViricides
NanoViricides, Inc., a leading global pioneer in broad-spectrum antivirals, achieves significant success in developing a drug against Measles with NV-387. The drug shows strong antiviral effectiveness in recent studies

NanoViricides NV-387 Clinical Stage Broad-spectrum Antivirals Measles

Accesswire

Published on 12/05/2025 at 02:35, 8 hours 56 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 9 hours 1 minute ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 10 hours 31 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 26 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 31 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 11:14, 17 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 11:08, 22 minutes ago

Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 12/05/2025 at 10:30, 1 hour 1 minute ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 1 hour 16 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 1 hour 51 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration

Les Echos

Published on 12/05/2025 at 08:45, 2 hours 46 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 2 hours 46 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 2 hours 49 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 17 hours 16 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 17 hours 31 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE